Health Technology Assessment (HTA) & PRA Lead

About the role

Lilly is seeking a strategic Health Technology Assessment (HTA) & Pricing, Reimbursement & Access (PRA) Lead for its Saudi Arabia affiliate. The role bridges economic evidence generation with capability building to support access strategies for Lilly’s portfolio across the Kingdom.

Key responsibilities

• Partner with PRA Leads and Market Access to develop and validate health economic models (cost‑effectiveness, budget impact, cost‑consequence) tailored to the Saudi healthcare environment.
• Produce HTA content and economic evidence for payer submissions to SFDA and public‑sector reimbursement bodies.
• Support the affiliate value narrative by translating clinical outcomes into payer‑relevant economic arguments.
• Design and deliver structured learning programs that elevate PRA and Key Account Management teams’ economic fluency.
• Collaborate with cross‑functional teams (Medical, Brand, Regulatory, Finance, Supply) to embed HTA thinking early in product planning.

Required profile

• Extensive experience in health economics, HTA, and market access within the pharmaceutical industry.
• Deep understanding of the Saudi healthcare system, reimbursement processes, and Vision 2030 initiatives.
• Proven ability to lead capability‑building initiatives and work cross‑functionally.

Required skills

• Health economic modeling
• Cost‑effectiveness analysis
• Budget impact analysis
• Cost‑consequence analysis
• HTA evidence generation

What we offer

• Opportunity to influence early access and sustained market presence of innovative medicines in Saudi Arabia.
• Collaborative, purpose‑driven environment within a global healthcare leader.